tiprankstipranks
Trending News
More News >
Traws Pharma (TRAW)
NASDAQ:TRAW
US Market

Traws Pharma (TRAW) Technical Analysis

Compare
1,853 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
6Neutral
6Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Traws Pharma’s (TRAW) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting Traws Pharma is a Sell.
Traws Pharma’s (TRAW) 20-Day exponential moving average is 1.48, while Traws Pharma’s (TRAW) share price is $1.65, making it a Buy.
Traws Pharma’s (TRAW) 50-Day exponential moving average is 1.90, while Traws Pharma’s (TRAW) share price is $1.65, making it a Sell.

Traws Pharma (TRAW) Pivot Points

Jun 07, 2025, 05:10 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.15
1.31
1.40
1.56
1.65
1.81
1.90
Fibonacci
1.31
1.41
1.47
1.56
1.66
1.72
1.81
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Traws Pharma (TRAW) Moving Averages

Jun 07, 2025, 05:10 PM
Period
Simple
Exponential
MA5
1.63Buy
1.59Buy
MA10
1.50Buy
1.52Buy
MA20
1.38Buy
1.48Buy
MA50
1.64Buy
1.90Sell
MA100
3.28Sell
3.02Sell
MA200
4.91Sell
4.99Sell
Traws Pharma’s (TRAW) 10-Day exponential moving average is 1.52, while Traws Pharma’s (TRAW) share price is $1.65, making it a Buy.
Traws Pharma’s (TRAW) 100-Day exponential moving average is 3.02, while Traws Pharma’s (TRAW) share price is $1.65, making it a Sell.
Traws Pharma’s (TRAW) stock price is $1.65 and Traws Pharma’s (TRAW) 50-day simple moving average is 1.64, creating a Buy signal.
Traws Pharma’s (TRAW) stock price is $1.65 and Traws Pharma’s (TRAW) 100-day simple moving average is 3.28, creating a Sell signal.
Traws Pharma’s (TRAW) stock price is $1.65 and Traws Pharma’s (TRAW) 200-day simple moving average is 4.91, creating a Sell signal.

Traws Pharma (TRAW) Technical Indicators

Jun 07, 2025, 05:10 PM
Name
Value
Implied Action
RSI (14)
54.14
Neutral
STOCH (9,6)
30.18
Neutral
STOCHRSI (14)
37.15
Neutral
MACD (12,26)
-0.01
Sell
ADX (14)
23.31
Neutral
Williams %R
-65.96
Buy
CCI (14)
96.53
Neutral
ATR (14)
0.27
-
Ultimate Oscillator
41.77
Neutral
ROC
38.66
Buy
Traws Pharma’s (TRAW) Relative Strength Index (RSI) is 54.14, creating a Neutral signal.
Traws Pharma’s (TRAW) Trend Strength Indicator (ADX) is 23.31, creating a Neutral signal.
Traws Pharma’s (TRAW) Commodity Channel Index (CCI) is 96.53, creating a Neutral signal.
Traws Pharma’s (TRAW) Price Rate of Change (ROC) is 38.66, creating a Buy signal.

FAQ

Is TRAW a Buy, Hold, or Sell?
Based on TRAW’s technical indicators, TRAW is a Buy.
    What is TRAW’s RSI (14)?
    TRAW’s RSI (14) is 54.14, which suggests TRAW is a Neutral.
      What is TRAW’s MACD?
      TRAW’s MACD is -0.01, which suggests TRAW is a Sell.
        What is TRAW’s 5-day moving average?
        TRAW’s 5-day moving average is 1.63, which suggests TRAW is a Buy.
          What is TRAW’s 20-day moving average?
          TRAW 20-day moving average is 1.38, which suggests TRAW is a Buy.
            What is TRAW’s 50-day moving average?
            TRAW’s 50-day moving average is 1.64, which suggests TRAW is a Buy.
              What is TRAW’s 200-day moving average?
              TRAW’s 200-day moving average is 4.91, which suggests TRAW is a Sell.
                What is TRAW’s Williams % R (14)?
                TRAW’s Williams % R (14) is -65.96, which suggests TRAW is a Buy.
                  What is TRAW’s CCI (14)?
                  TRAW’s CCI (14) is 96.53, which suggests TRAW is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis